A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the general population.

The drug is cleared to treat complicated intra-abdominal infections, including those caused by tough-to-control, gram-negative bacteria.

Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva’s generic copy of Auvelity from entering the U.S. market until at least 2038.

In what one analyst called a “unique situation,” the company stopped dosing patients on the recommendation of trial monitors, but doesn’t yet know what led to their decision.

China’s NMPA has granted approval for Keymed Biosciences’ supplemental NDA of Stapokibart to treat seasonal allergic rhinitis.

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Data from the Phase III FRONTIER3 trial found that 98% of caregivers prefer Mim8 for hemophilia A over other treatments.

Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting event.

Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for diabetes insipidus.

Biljana Naumovic discusses how a new study attempted to bring in patients from underserved communities.

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI identifies the risks associated with relying heavily on open-access AI models in terms of data security, intellectual property, and […]

In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, explores the contributing factors growing distrust and uncertainty surrounding social media.

The latest news for pharma industry insiders.

Antibody-drug conjugates (ADCs) are revolutionizing oncology, but success requires precision diagnostics.

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing motor fluctuations in adults with advanced Parkinson disease.

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement of new tariffs on imported goods – 25% on Canada and Mexico, both paused for 30 days, and 10% on China – with the potential […]

Sanofi has agreed to purchase its own shares worth €2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.